Global Orthobiologics Market

Global Orthobiologics Market Size, Share, Growth Analysis, By Product(Demineralized Bone Matrix (DBM), Allograft), By Application(Spinal Fusion, Trauma Repair), By End-Use(Hospitals, Ambulatory Surgical Centers & Orthopedic Clinics) - Industry Forecast 2024-2031


Report ID: SQMIG35D2070 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 92 | Figures: 76

Global Orthobiologics Market Dynamics

Orthobiologics Market Driver

Viscosupplements are in high demand to support the market.

  • One of the main issues affecting the elderly population is knee osteoarthritis, which is extensively treated with viscosupplements. Hyaluronic acid injections known as viscosupplements are given right into the joints. High product costs, new manufacturer entrants, and recent marketing approvals are the major variables linked to the expansion of viscosupplements segments. Additionally, the viscosupplements segments are benefiting from better reimbursement policies. Given the aforementioned aspects, it is projected that the increased demand for viscosupplements will propel the growth of the worldwide orthobiologics market during the forecast period.

Increase in incidences of disease and disorders

  • It is projected that the market for orthobiologics would grow as a result of the rise in spinal diseases and disorders. Additionally, the frequency of traffic accidents is also predicted to increase the market.

Orthobiologics Market Restraints

Patient’s preference of treatment over invasive procedures.

  • It is predicted that the growing patient desire for minimally invasive procedures will restrain the expansion of the orthobiologics market. The market for orthobiologics may face additional difficulties in the near future due to the negative effects of Bmp-based therapy.

Surging prices for orthobiologics-based treatments.

  • It is also estimated that the rise in the price of orthobiologics-based treatments may restrain the market's expansion throughout the forecast period. The market is constrained by complex synthesis procedures, manufacturing regulations, and high production prices. Orthobiologics goods and treatments have high costs and insufficient reimbursements, which are additional key issues limiting this market's growth. One of the major obstacles to the expansion of the global orthobiologics market is the high cost of orthobiologics treatments and products.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Orthobiologics Market size was valued at USD 7.63 billion in 2019 and is poised to grow from USD 8.56 billion in 2023 to USD 12.33 billion by 2031, growing at a CAGR of 5.4% in the forecast period (2024-2031).

Medtronic has become the market leader because of the excellent introduction and quick uptake of infuse bone morphogenetic protein. Medtronic is anticipated to hold the largest share during the forecast period due to infuse's higher price, strong sales team, and April 2018 FDA clearance for use in a new indication for spine surgery. Musculoskeletal Transplant Foundation, Zimmer Biomet, Wright Medical Group N.V., DePuy Synthes (Johnson & Johnson Services, Inc.), Stryker, Sea Spine, Bioventus, RTI Surgical Holdings, Inc. and Anika Therapeutics, Inc. are additional companies that compete on the international market. 'Johnson & Johnson', 'Stryker Corporation', 'Medtronic plc', 'Zimmer Biomet Holdings, Inc.', 'DePuy Synthes', 'NuVasive, Inc.', 'Globus Medical, Inc.', 'Orthofix Medical Inc.', 'Wright Medical Group N.V.', 'RTI Surgical, Inc.', 'Bioventus LLC', 'Seaspine Holdings Corporation', 'Alphatec Holdings, Inc.', 'Kuros Biosciences AG', 'CONMED Corporation', 'Xtant Medical Holdings, Inc.', 'Amedica Corporation', 'Cytomedix Inc.', 'Histogenics Corporation', 'Harvest Technologies Corporation'

One of the main issues affecting the elderly population is knee osteoarthritis, which is extensively treated with viscosupplements. Hyaluronic acid injections known as viscosupplements are given right into the joints. High product costs, new manufacturer entrants, and recent marketing approvals are the major variables linked to the expansion of viscosupplements segments. Additionally, the viscosupplements segments are benefiting from better reimbursement policies. Given the aforementioned aspects, it is projected that the increased demand for viscosupplements will propel the growth of the worldwide orthobiologics market during the forecast period.

The global orthobiologics market is anticipated to develop due to the high prevalence of sports-related injuries. For instance, according to a study published in November 2018 titled "Results on sports-related injuries in children from NHS emergency care dataset Oxfordshire pilot: an ecological study," 47.4 percent of emergency department visits related to sports injuries were for children between the ages of 0 and 19 and roughly 23.5 percent of admissions related to sports injuries for all ages.

Orthopedic Surgery in outpatient settings is increasing, favoring the North American Market. North America's market is estimated to rule the industry for the entire forecast year. The market in North America may see growth between 2019 and 2026 as a result of the business strategies of top American manufacturers, benevolent reimbursement policies, rising prevalence of degenerative bone diseases, and rising trend of orthopaedic procedures in outpatient settings. Due to the recent marketing approval for Cingal, a viscosupplement, in Europe, Europe is anticipated to be the second most lucrative region with a sizable market share..

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Orthobiologics Market

Product ID: SQMIG35D2070

$5,300
BUY NOW GET FREE SAMPLE